WSR 03-23-023




[ Filed November 12, 2003, 9:26 a.m. ]

Subject of Possible Rule Making: Evidence-based prescription drug program, chapter 296-20 WAC, Medical aid rules.

Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 51.04.020, 70.14.050.

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: SB 6088, chapter 29, Laws of 2003, allows the agencies involved in state purchased health care to establish an evidence-based prescription drug program. Furthermore, this bill directs these agencies to adopt rules governing practitioner endorsement and use of any list developed as part of the evidence-based prescription drug program.

Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: The Health Care Authority (HCA-UMP), Department of Social and Health Services (DSHS-MAA), and the Department of Labor and Industries (L&I) are coordinating rule-making activities for the evidence-based prescription drug program. HCA will take the lead role to adopt common rules for this program. L&I will adopt additional rules that are specific to the administration of this program within L&I.

Process for Developing New Rule: The agency will develop this rule in coordination with the following stakeholder groups; Worker's Compensation Advisory Committee, Washington State Medical Association, Washington State Pharmacy Association, Department of Health (Board of Pharmacy), Washington Retail Association, National Association of Chain Drug Stores.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Jami Lifka, Department of Labor and Industries, Office of the Medical Director, P.O. Box 44321, Olympia, WA 98504-4321, phone (360) 902-4941, or fax (360) 902-6315.

November 12, 2003

Paul Trause


Legislature Code Reviser 


Washington State Code Reviser's Office